Skip to main content

Charles River Laboratories free cash flow

  • CRL · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$337.97−0.83%Close 13 Nov 2026 · Market value $16.04B

Charles River Laboratories's free cash flow was $518 million for fiscal year 2025 (the twelve months to 27 Dec 2025), up 3.4% from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 26 Sep 2026) it was $207 million, up 16.3% from a year earlier.

Over the four quarters to 26 Sep 2026, free cash flow was $400 million.

From Charles River Laboratories's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.

Fiscal 2025
$518M
+3.4%
Q3 FY2026
$207M
+16.3% on a year
Growth over 9 years
+7.9%
a year, FY 2016–FY 2025

Free cash flow by fiscal year

$262MFY 2016$236MFY 2017−9.9%$301MFY 2018+27.8%$340MFY 2019+13.1%$380MFY 2020+11.6%$532MFY 2021+40.0%$295MFY 2022−44.6%$365MFY 2023+23.9%$502MFY 2024+37.3%$518MFY 2025+3.4%

Change on the year before, under each year. From FY 2016 to FY 2025, Charles River Laboratories's free cash flow went from $262 million to $518 million, a compound annual change of +7.9%; the highest was $532 million in FY 2021.

Charles River Laboratories free cash flow, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Free cash flow$262M$236M$301M$340M$380M$532M$295M$365M$502M$518M
Period end31 Dec 201630 Dec 201729 Dec 201828 Dec 201926 Dec 202025 Dec 202131 Dec 202230 Dec 202328 Dec 202427 Dec 2025

Free cash flow by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Charles River Laboratories free cash flow, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Free cash flow$83.7M$112M$169M$178M$58.6M−$14.8M$149M$207M
Period end28 Dec 202429 Mar 202528 Jun 202527 Sep 202527 Dec 202528 Mar 202627 Jun 202626 Sep 2026

How free cash flow is measured

Free cash flow is the cash generated by operations less capital expenditure: the cash a company has left to repay debt, pay dividends, buy back shares or invest. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Charles River Laboratories's other figures

Free cash flow of comparable companies

Everything on CRL, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.